FDA.reportPublic FDA data

atezolizumab-hyaluronidase-tqjs 1875 MG / 30,000 UNT per 15 ML Injection

RxCUI
2693892
RxNorm name
atezolizumab-hyaluronidase-tqjs 1875 MG / 30,000 UNT per 15 ML Injection
Display name
atezolizumab-hyaluronidase-tqjs 1875 MG / 30,000 UNT per 15 ML Injection
Full name
atezolizumab-hyaluronidase-tqjs 1875 MG / 30,000 UNT per 15 ML Injection
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:12

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
761347Tecentriq Hybrezaatezolizumab and hyaluronidase-tqjs351(a)Rx2026-09-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
a617b089-ce66-464b-987b-b45d029b4d6fatezolizumab-hyaluronidase-tqjs 1875 MG / 30,000 UNT in 15 ML Injection [PSN] · 15 ML atezolizumab-tqjs 125 MG/ML / hyaluronidase-tqjs 2000 UNT/ML Injection [SCD] · atezolizumab-hyaluronidase-tqjs 1875 MG / 30,000 UNT per 15 ML Injection [SY]37These highlights do not include all the information needed to use TECENTRIQ HYBREZA safely and effectively. See full prescribing information for TECENTRIQ HYBREZA. TECENTRIQ HYBREZA ® (atezolizumab and hyaluronidase-tqjs) injection, for subcutaneous use Initial U.S. Approval: 202420260520